Rezultati pretrage - Andrea Navarria

  • Prikaz rezultata 1 – 8 od 8
Detaljiziraj rezultate
  1. 1
    A randomized study investigating the effect of omeprazole on the pharmacokinetics of oral semaglutide

    A randomized study investigating the effect of omeprazole on the pharmacokinetics of oral semaglutide od Tine A. Bækdal, Astrid Breitschaft, Andrea Navarria, Cilie W. Hansen

    Izdano 2018
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  2. 2
    Efficacy and Safety of Semaglutide for Type 2 Diabetes by Race and Ethnicity: A Post Hoc Analysis of the SUSTAIN Trials

    Efficacy and Safety of Semaglutide for Type 2 Diabetes by Race and Ethnicity: A Post Hoc Analysis of the SUSTAIN Trials od Cyrus Desouza, Bertrand Cariou, Satish K. Garg, Nanna L. Lausvig, Andrea Navarria, Vivian Fonseca

    Izdano 2019
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  3. 3
    Clinical Pharmacokinetics of Oral Semaglutide: Analyses of Data from Clinical Pharmacology Trials

    Clinical Pharmacokinetics of Oral Semaglutide: Analyses of Data from Clinical Pharmacology Trials od Rune Viig Overgaard, Andrea Navarria, Steen H. Ingwersen, Tine A. Bækdal, Rasmus Juul Kildemoes

    Izdano 2021
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  4. 4
    Levels of circulating semaglutide determine reductions in HbA1c and body weight in people with type 2 diabetes

    Levels of circulating semaglutide determine reductions in HbA1c and body weight in people with type 2 diabetes od Rune Viig Overgaard, CHRISTIN L. HERTZ, Steen H. Ingwersen, Andrea Navarria, Daniel J. Drucker

    Izdano 2021
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  5. 5
    Efficacy and Hypoglycemia Profile of Once-Weekly Insulin Icodec vs. Once-Daily Comparators across Demographic Subgroups

    Efficacy and Hypoglycemia Profile of Once-Weekly Insulin Icodec vs. Once-Daily Comparators across Demographic Subgroups od Ildiko Lingvay, Julie Krogsdahl Bache, Cyrus Desouza, Mariana Fragão-Marques, Andrea Navarria, Shehla Shaikh, André Gustavo Daher Vianna

    Izdano 2025
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  6. 6
    Scopolamine Rapidly Increases Mammalian Target of Rapamycin Complex 1 Signaling, Synaptogenesis, and Antidepressant Behavioral Responses

    Scopolamine Rapidly Increases Mammalian Target of Rapamycin Complex 1 Signaling, Synaptogenesis, and Antidepressant Behavioral Responses od Bhavya Voleti, Andrea Navarria, Rong-Jian Liu, Mounira Banasr, Nanxin Li, Rose Z. Terwilliger, Gerard Sanacora, Tore Eid, George K. Aghajanian, Ronald S. Duman

    Izdano 2013
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  7. 7
    Rapid antidepressant actions of scopolamine: Role of medial prefrontal cortex and M1-subtype muscarinic acetylcholine receptors

    Rapid antidepressant actions of scopolamine: Role of medial prefrontal cortex and M1-subtype muscarinic acetylcholine receptors od Andrea Navarria, Eric S. Wohleb, Bhavya Voleti, Kristie T. Ota, Sophie Dutheil, Ashley E. Lepack, Jason M. Dwyer, Manabu Fuchikami, Astrid Becker, Filippo Drago, Ronald S. Duman

    Izdano 2015
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  8. 8
    Dose-response, efficacy, and safety of oral semaglutide monotherapy in Japanese patients with type 2 diabetes (PIONEER 9): a 52-week, phase 2/3a, randomised, controlled trial

    Dose-response, efficacy, and safety of oral semaglutide monotherapy in Japanese patients with type 2 diabetes (PIONEER 9): a 52-week, phase 2/3a, randomised, controlled trial od Yuichiro Yamada, Hideki Katagiri, Yoshiyuki Hamamoto, Srikanth Deenadayalan, Andrea Navarria, Keiji Nishijima, Yutaka Seino, Yasushi Fukushima, Yoshiyuki Hamamoto, Hisatomi Arima, Yumiko Ide, Satoshi Inoue, Tatsushi Kawada, H Kim, Arihiro Kiyosue, K Matoba, Osamu Matsuoka, H. Nishimura, Masahiro Noguchi, Takeshi Osonoi, Shojiro Sawada, Yoshiyuki Shibasaki, Koki Shin, Yuichiro Yamada

    Izdano 2020
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:

Alati za pretragu: